financetom
Business
financetom
/
Business
/
Todd Boehly-backed Accelerant files for NYSE listing as IPO market gathers steam
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Todd Boehly-backed Accelerant files for NYSE listing as IPO market gathers steam
Jun 30, 2025 3:24 PM

June 30 (Reuters) - Billionaire sports financier Todd

Boehly-backed insurance tech company Accelerant filed for an

initial public offering in the United States on Monday, almost

two years after it first considered a stock market flotation.

The move comes as the IPO market, which had been languishing

amid economic uncertainty and elevated interest rates, is

beginning to recover.

Strong debuts in recent weeks and improving sentiment toward

equities are prompting companies to move forward with their

listings, which they had delayed in the wake of a dull market.

Disruptions related to tariffs had briefly derailed the

stock market in April, but the S&P 500 and the Nasdaq

indexes reached record closing highs on Monday, capping

their best quarter in more than a year.

Accelerant recorded $178 million in revenue in the three

months ended March 31, a 39% jump from the year before. Its net

income was $7.8 million, compared with $2.1 million in 2024.

Proceeds from the IPO will be used to redeem some

convertible preference shares, and to pay management fees to its

majority investor Altamont Capital Partners, a private equity

firm.

Accelerant, founded in 2018, is an insurance marketplace

that connects niche insurance sellers with institutional

investors, using data to make the process faster, cheaper and

smarter.

Morgan Stanley, Goldman Sachs, BMO Capital Markets and RBC

Capital Markets are among the underwriters for the IPO. The

company plans to list on the NYSE under ticker symbol "ARX".

Boehly is one of the most active investors in sports, media

and financial services.

(Reporting by Niket Nishant in Bengaluru; Editing by Shinjini

Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Design software maker Figma extends gains after blockbuster NYSE trading debut
Design software maker Figma extends gains after blockbuster NYSE trading debut
Aug 1, 2025
(Reuters) -Design software maker Figma's shares rose another 10% in premarket trading on Friday, extending strong debut-day gains after a blowout U.S. initial public offering that has reignited the tech listing market. The San Francisco, California-based company's shares closed at $115.5 on Thursday, compared with its IPO price of $33. The 250% surge lifted Figma's market value to nearly $68...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Microsoft in Brazilian antitrust regulator's crosshairs after Opera complaint
Microsoft in Brazilian antitrust regulator's crosshairs after Opera complaint
Aug 1, 2025
BRUSSELS (Reuters) -Brazil's antitrust enforcer CADE has opened an investigation into Microsoft, days after Norwegian browser Opera complained about Microsoft's Edge, according to a CADE statement published late Thursday on its website. Opera, in its complaint filed on Tuesday, alleged that Microsoft pre-installs Edge as the default browser across Windows devices and computers, thereby preventing rivals from competing on the...
Moderna Wins UK Patent Dispute Against Pfizer, BioNTech
Moderna Wins UK Patent Dispute Against Pfizer, BioNTech
Aug 1, 2025
07:00 AM EDT, 08/01/2025 (MT Newswires) -- Moderna ( MRNA ) said Friday that the UK Court of Appeal has upheld the validity of its EP'949 patent, affirming an earlier court ruling that the patent was infringed by Pfizer ( PFE ) and BioNTech's (BNTX) Comirnaty COVID-19 vaccine. The company said the patent covers one of its foundational technologies that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved